Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 6Radiotherapy 5Carboplatin 5capmatinib 2Radiosurgery 2Gemcitabine 2tetrathiomolybdate 1spartalizumab 1pembrolizumab 1palbociclib 1onartuzumab 1nintedanib 1fludarabine phosphate 1fludarabine 1efaproxiral 1durvalumab 1binimetinib 1aldesleukin 1Vinorelbine 1Technetium Tc 99m Sestamibi 1Taxes 1Sorafenib 1Platinum 1Nivolumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunotherapy 1Immunoenzyme Techniques 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma of Lung × Technetium Tc 99m Sestamibi × Clear all
NCT00560495 2022-10-03

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Withdrawn
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡